{"id":"W2139511378","doi":"10.1016/s0140-6736(06)69446-4","title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","year":2006,"lang":"en","type":"article","venue":"The Lancet","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":2595,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Placebo; Discontinuation; Adverse effect; Interim analysis; Clinical endpoint; Imatinib; GiST; Nausea; Hazard ratio; Imatinib mesylate; Oncology; Clinical trial; Surgery; Gastroenterology; Cancer; Stromal cell; Pathology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}